Editorial Director, PMGroup
Posted in Health on September 2, 2017
Most of the time mobile fitness apps offer to log and track a dizzying array of measurements.
My Fitbit app, for example, can track my exercise, the water I drink, my weight, how I’ve slept and what I’ve eaten, though I think it stops short of requesting my inside leg measurement.
So it was refreshing to see the launch last week of a user-friendly fitness app aimed at those in middle age who would benefit from regularly taking a brisk* 10 minute walk. Read the rest of this entry »
Posted in The Online World on August 1, 2017
First introduced in the Harvard Business Review in 2015, the Digital Evolution Index aims to trace the emergence of a ‘digital planet’ as technology displaces traditional interactions.
Recently given its first update, the Index analyses the state and rate of digital evolution across 60 countries, placing them into one of four zones. Read the rest of this entry »
Posted in Music on July 23, 2017
SoundCloud staff reductions cut deep, Twitter strikes live-streaming deal with Live Nation, Pandora slims down its operations, internet music pioneer eMusic relaunches and Spotify defends itself from ‘fake artist’ accusations.
SoundCloud has cut 40% of its staff in a defensive move to protect its independence within an increasingly tough online music market. The decision comes despite doubling its revenue in the last 12 months, but co-founder Alex Ljung said that, alongside the cost-cutting, further growth is needed from its advertising and subscription revenue streams. Less than a week after that announcement Ljung was forced to put out a statement saying ‘SoundCloud is here to stay’. Read the rest of this entry »
Posted in Pharma on June 30, 2017
It was a bumper issue of PME this month as we encompassed creativity, communications and consumerism, and tackled different strands of how pharma looks to reach and engage with its stakeholders.
On an industry level the German pharma market looks set for stable, if not strong, growth over the next four years, but it’s clearly anyone’s guess what will happen over that timeframe to the UK’s political landscape, and how that will in turn affect the industry.
What we can say with certainty is that European regulators aren’t waiting for the region’s politicians to thrash out a deal on the post-Brexit landscape. Instead the last month has seen concrete developments in the future shape of the regulatory environment, with a set of guidance now available, and – more recently – a delay to deciding the new location of the EMA. Read the rest of this entry »
Posted in Pharma on June 1, 2017
Stranger things have been said by politicians, particularly recently, but I can’t have been the only person surprised by Greg Clark’s turn at this year’s ABPI annual conference.
Asked about the EMA Clark, the UK government’s spokesperson for business, energy and industrial strategy, told the UK pharma gathering he wanted “as many [European] institutions here as possible”, adding: “I would like the EMA to continue to be within the UK.”
Meanwhile, in the real world, the temperature is certainly rising on the issue of where Europe’s regulatory authority will be located, with ‘not in the UK’ seemingly the only certainty at the moment. A decision from the EU’s heads of government is expected in the Autumn, and Copenhagen, Barcelona, Dublin and Lisbon are among those stepping up their public campaigns to host the EMA. Read the rest of this entry »